| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.2 |